These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9796366)

  • 1. Functional imaging of neurotransmitter systems in movement disorders.
    Ilgin N
    Q J Nucl Med; 1998 Sep; 42(3):179-92. PubMed ID: 9796366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET evaluation of the dopamine system of the human brain.
    Volkow ND; Fowler JS; Gatley SJ; Logan J; Wang GJ; Ding YS; Dewey S
    J Nucl Med; 1996 Jul; 37(7):1242-56. PubMed ID: 8965206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Functional neuroimaging in movement disorders].
    Borbély K
    Orv Hetil; 2001 Oct; 142(43):2347-55. PubMed ID: 11760452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.
    Tissingh G; Bergmans P; Winogrodzka A; Stoof JC; Wolters EC; Booij J; Van Royen EA
    J Nucl Med; 1997 Aug; 38(8):1271-2. PubMed ID: 9255164
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.
    Ishikawa T; Dhawan V; Kazumata K; Chaly T; Mandel F; Neumeyer J; Margouleff C; Babchyck B; Zanzi I; Eidelberg D
    J Nucl Med; 1996 Nov; 37(11):1760-5. PubMed ID: 8917170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine receptors in Parkinson's disease: imaging studies.
    Stoessl AJ; de la Fuente-Fernández R
    Adv Neurol; 2003; 91():65-71. PubMed ID: 12442664
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters.
    Fischman AJ; Bonab AA; Babich JW; Palmer EP; Alpert NM; Elmaleh DR; Callahan RJ; Barrow SA; Graham W; Meltzer PC; Hanson RN; Madras BK
    Synapse; 1998 Jun; 29(2):128-41. PubMed ID: 9593103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-photon emission computed tomography of the dopamine transporter in parkinsonism.
    Seibyl JP
    J Neuroimaging; 1999 Oct; 9(4):223-8. PubMed ID: 10540602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging studies in movement disorders.
    Seibyl JP
    Semin Nucl Med; 2003 Apr; 33(2):105-13. PubMed ID: 12756643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can SPET imaging of dopamine uptake sites replace PET imaging in Parkinson's disease? For.
    Tatsch K
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):711-4. PubMed ID: 11976813
    [No Abstract]   [Full Text] [Related]  

  • 11. Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism.
    Booij J; Tissingh G; Winogrodzka A; van Royen EA
    Eur J Nucl Med; 1999 Feb; 26(2):171-82. PubMed ID: 9933352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.
    Jeon BS; Jeong JM; Park SS; Kim JM; Chang YS; Song HC; Kim KM; Yoon KY; Lee MC; Lee SB
    Ann Neurol; 1998 Jun; 43(6):792-800. PubMed ID: 9629849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [123I]FPCIT SPECT.
    Booij J; Hemelaar TG; Speelman JD; de Bruin K; Janssen AG; van Royen EA
    J Nucl Med; 1999 May; 40(5):753-61. PubMed ID: 10319746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain.
    Madras BK; Gracz LM; Fahey MA; Elmaleh D; Meltzer PC; Liang AY; Stopa EG; Babich J; Fischman AJ
    Synapse; 1998 Jun; 29(2):116-27. PubMed ID: 9593102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine transporter imaging and SPECT in diagnostic work-up of Parkinson's disease: a decision-analytic approach.
    Dodel RC; Höffken H; Möller JC; Bornschein B; Klockgether T; Behr T; Oertel WH; Siebert U
    Mov Disord; 2003 Oct; 18 Suppl 7():S52-62. PubMed ID: 14531047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External radioactive reference markers in SPECT imaging of the dopamine system.
    Vines DC; Ivo BD; Ballinger JR; Ichise M
    J Nucl Med Technol; 1999 Jun; 27(2):112-6. PubMed ID: 10353107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine transporter imaging.
    Lees AJ; Grosset DG
    Mov Disord; 2003 Oct; 18 Suppl 7():S1-2. PubMed ID: 14531038
    [No Abstract]   [Full Text] [Related]  

  • 18. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.
    Booij J; Habraken JB; Bergmans P; Tissingh G; Winogrodzka A; Wolters EC; Janssen AG; Stoof JC; van Royen EA
    J Nucl Med; 1998 Nov; 39(11):1879-84. PubMed ID: 9829575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous SPECT studies of pre- and postsynaptic dopamine binding sites in baboons.
    Dresel SH; Kung MP; Huang XF; Plössl K; Hou C; Meegalla SK; Patselas G; Mu M; Saffer JR; Kung HF
    J Nucl Med; 1999 Apr; 40(4):660-6. PubMed ID: 10210226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET and movement disorders.
    Brooks DJ; Frackowiak RS
    J Neurol Neurosurg Psychiatry; 1989 Jun; Suppl(Suppl):68-77. PubMed ID: 2666580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.